BEDMINSTER, N.J., Feb. 4 /CNW/ -- NPS Pharmaceuticals, Inc. (Nasdaq:
NPSP) announced today that Francois Nader, M.D., executive vice president and
chief operating officer, is scheduled to present at the 10th Annual BIO CEO
and Investor Conference in New York on Monday, February 11, 2008 at 1:15 p.m.
ET. The presentation will be available as a live webcast with a replay
available approximately three hours after the presentation has concluded.
Interested parties may access the webcast from the NPS website,
About NPS Pharmaceuticals
NPS Pharmaceuticals is a biopharmaceutical company focused on the
development and commercialization of small molecules and recombinant proteins
as drugs, primarily for the treatment of metabolic, bone and mineral, and
central nervous system disorders. The Company has drug candidates in various
stages of clinical development. Additional information is available on the NPS
For further information:
For further information: Susan Mesco of NPS Pharmaceuticals, Inc.,
+1-908-450-5516 Web Site: http://www.npsp.com